HomeCompareAMMJ vs PFE

AMMJ vs PFE: Dividend Comparison 2026

AMMJ yields 500000.00% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AMMJ wins by $4.663521010693878e+33M in total portfolio value
10 years
AMMJ
AMMJ
● Live price
500000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.663521010693878e+33M
Annual income
$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00
Full AMMJ calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — AMMJ vs PFE

📍 AMMJ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAMMJPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AMMJ + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AMMJ pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AMMJ
Annual income on $10K today (after 15% tax)
$42,500,000.00/yr
After 10yr DRIP, annual income (after tax)
$3,962,433,917,637,946,000,000,000,000,000,000,000,000.00/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, AMMJ beats the other by $3,962,433,917,637,946,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AMMJ + PFE for your $10,000?

AMMJ: 50%PFE: 50%
100% PFE50/50100% AMMJ
Portfolio after 10yr
$2.331760505346939e+33M
Annual income
$2,330,843,480,963,498,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.96%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

AMMJ
No analyst data
Altman Z
-15.8
Piotroski
2/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AMMJ buys
0
PFE buys
0
No recent congressional trades found for AMMJ or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAMMJPFE
Forward yield500000.00%6.13%
Annual dividend / share$2.00$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%13.2%
Portfolio after 10y$4.663521010693878e+33M$49.6K
Annual income after 10y$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00$26,258.71
Total dividends collected$4.6634009849658873e+33M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: AMMJ vs PFE ($10,000, DRIP)

YearAMMJ PortfolioAMMJ Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$50,010,700$50,000,000.00$9,153$693.39+$50.00MAMMJ
2$233,748,371,262$233,694,859,813.08$8,593$849.25+$233748.36MAMMJ
3$1,021,074,511,412,696$1,020,824,400,655,446.10$8,336$1,066.78+$1021074511.40MAMMJ
4$4,168,597,328,794,951,700$4,167,504,779,067,739,000.00$8,437$1,384.80+$4168597328794.94MAMMJ
5$15,905,475,114,600,665,000,000$15,901,014,715,458,854,000,000.00$9,013$1,875.40+$15905475114600664.00MAMMJ
6$56,718,938,532,531,060,000,000,000$56,701,919,674,158,435,000,000,000.00$10,306$2,680.72+$56718938532531060736.00MAMMJ
7$189,031,807,435,623,860,000,000,000,000$188,971,118,171,394,040,000,000,000,000.00$12,820$4,101.38+$1.8903180743562385e+23MAMMJ
8$588,799,810,476,518,260,000,000,000,000,000$588,597,546,442,562,100,000,000,000,000,000.00$17,673$6,826.70+$5.8879981047651824e+26MAMMJ
9$1,714,064,268,114,722,600,000,000,000,000,000,000$1,713,434,252,317,512,700,000,000,000,000,000,000.00$27,543$12,591.86+$1.7140642681147225e+30MAMMJ
10$4,663,521,010,693,878,300,000,000,000,000,000,000,000$4,661,686,961,926,996,000,000,000,000,000,000,000,000.00$49,560$26,258.71+$4.663521010693878e+33MAMMJ

AMMJ vs PFE: Complete Analysis 2026

AMMJStock

American Cannabis Company, Inc., together with its subsidiary, Hollister & Blacksmith, Inc., provides solutions for businesses operating in the regulated cannabis industry in the United States and Canada. The company offers consulting services for companies associated with the cannabis and hemp industries in various stages of development, such as cannabis and hemp business planning, license applications, growth strategies, and monitoring, as well as cultivation build-out oversight services, cannabis regulatory compliance, and compliance audit services. It also sells products and equipment used in the cultivation, processing, transportation, or retail sale of cannabis, such as The Satchel, a pouch-like case designed as a child-proof exit package solution for the regulated cannabis industry; SoHum Living Soil, a just-add-water soil; High Density Cultivation System, which ensures that space is used in an efficient manner; The Cultivation Cube, a self-contained and scalable cultivation system; and other products for cultivation operations, medicinal and recreational cannabis dispensary operations, and infused-products. In addition, the company offers advisory and consulting services specific to design industry-specific products and facilities, and manage a strategic group partnership that offers customer products commonly used in the industry. American Cannabis Company, Inc. was founded in 2013 and is headquartered in Denver, Colorado.

Full AMMJ Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this AMMJ vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AMMJ vs SCHDAMMJ vs JEPIAMMJ vs OAMMJ vs KOAMMJ vs MAINAMMJ vs JNJAMMJ vs MRKAMMJ vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.